<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="459">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02091726</url>
  </required_header>
  <id_info>
    <org_study_id>Unicirc 003</org_study_id>
    <nct_id>NCT02091726</nct_id>
  </id_info>
  <brief_title>Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive</brief_title>
  <acronym>Unicirc003</acronym>
  <official_title>Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Simunye Primary Health Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Simunye Primary Health Care</source>
  <oversight_info>
    <authority>South Africa: Human Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a field trial of the Unicirc instrument to excise the foreskin, plus use of
      cyanoacrylate tissue adhesive to seal the wound.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Time for Procedure</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>Intraoperative time, total</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Completely Healed at 4 Weeks</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Definition: Completely epithelialized; no superficial ulcerations or granulation tissue present</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound Separation</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Wound separation caused by adhesive failure (minor --requires no treatment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmetic Result Excellent</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Excellent: scar line straight without any irregularity Irregular: Some irregularity to scar line Scalloped: wavy appearane to scar line</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant Fully Satisfied and Would Recommend to Friends and Family</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Yes to both of the following questions: Are you fully satisfied with your circumcision result? Would you recommend circumcision to friends or family?</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Male Circumcision</condition>
  <arm_group>
    <arm_group_label>Unicirc with tissue adhesive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Unicirc instrument plus cyanoacrylate tissue adhesive</intervention_name>
    <description>Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
    <arm_group_label>Unicirc with tissue adhesive</arm_group_label>
    <other_name>Unicirc</other_name>
    <other_name>Cyanoacrylate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men at least 18 years of age

        Exclusion Criteria:

          -  Poor general health

          -  Anatomical abnormalities that would complicate circumcision

          -  Bleeding disorder

          -  Ongoing infection

          -  Cannot attend followup visits
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Norman Goldstuck, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Obstetrics and Gynaecology, Tygerberg Hospital, Cape Town, South Africa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Simunye Primary Healthcare</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 16, 2015</lastchanged_date>
  <firstreceived_date>March 14, 2014</firstreceived_date>
  <firstreceived_results_date>December 1, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Simunye Primary Health Care</investigator_affiliation>
    <investigator_full_name>Peter Millard</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Circumcision</keyword>
  <keyword>HIV prevention</keyword>
  <keyword>Surgical device</keyword>
  <keyword>Cyanoacrylate</keyword>
  <keyword>Tissue Adhesive</keyword>
  <keyword>voluntary</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Three generalist physicians (GPs) performed the circumcisions in individual consultation rooms in their own primary health care clinic.
The study took place between January 20 and July 4, 2014.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Unicirc With Tissue Adhesive</title>
          <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="110"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>1 Week Followup</title>
              <participants_list>
                <participants group_id="P1" count="110"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>4 Week Followup</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Volunteers</population>
      <group_list>
        <group group_id="B1">
          <title>Unicirc With Tissue Adhesive</title>
          <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="110"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="110"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="110"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>South Africa</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="110"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time for Procedure</title>
        <description>Intraoperative time, total</description>
        <time_frame>1 hour</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Unicirc With Tissue Adhesive</title>
            <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="110"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Time for Procedure</title>
            <description>Intraoperative time, total</description>
            <units>Min</units>
            <param>Median</param>
            <dispersion>Inter-Quartile Range</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="9.0" lower_limit="9.0" upper_limit="10.0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Completely Healed at 4 Weeks</title>
        <description>Definition: Completely epithelialized; no superficial ulcerations or granulation tissue present</description>
        <time_frame>4 weeks</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Unicirc With Tissue Adhesive</title>
            <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="104"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Completely Healed at 4 Weeks</title>
            <description>Definition: Completely epithelialized; no superficial ulcerations or granulation tissue present</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="94"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wound Separation</title>
        <description>Wound separation caused by adhesive failure (minor --requires no treatment)</description>
        <time_frame>4 weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>Wound dehiscence &lt; 2 cm. None required treatment. There were no participants with wound dehiscence &gt; 2 cm.</population>
        <group_list>
          <group group_id="O1">
            <title>Unicirc With Tissue Adhesive</title>
            <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="110"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Wound Separation</title>
            <description>Wound separation caused by adhesive failure (minor --requires no treatment)</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Separation &gt; 2 cm longitudinally</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Separation &lt; 2 cm longitudinally</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cosmetic Result Excellent</title>
        <description>Excellent: scar line straight without any irregularity Irregular: Some irregularity to scar line Scalloped: wavy appearane to scar line</description>
        <time_frame>4 weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>104 men came for their 4-week followup but the doctor(s) failed to note the cosmetic result in 2 men.</population>
        <group_list>
          <group group_id="O1">
            <title>Unicirc With Tissue Adhesive</title>
            <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="102"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Cosmetic Result Excellent</title>
            <description>Excellent: scar line straight without any irregularity Irregular: Some irregularity to scar line Scalloped: wavy appearane to scar line</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="101"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participant Fully Satisfied and Would Recommend to Friends and Family</title>
        <description>Yes to both of the following questions: Are you fully satisfied with your circumcision result? Would you recommend circumcision to friends or family?</description>
        <time_frame>4 weeks</time_frame>
        <safety_issue>No</safety_issue>
        <population>104 men came for their 4-week followup, but 1 man did not complete the satisfaction questions.</population>
        <group_list>
          <group group_id="O1">
            <title>Unicirc With Tissue Adhesive</title>
            <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="103"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Participant Fully Satisfied and Would Recommend to Friends and Family</title>
            <description>Yes to both of the following questions: Are you fully satisfied with your circumcision result? Would you recommend circumcision to friends or family?</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="103"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Time period: 4 weeks</time_frame>
      <desc>Active followup of volunteers at 1 and 4 weeks</desc>
      <group_list>
        <group group_id="E1">
          <title>Unicirc With Tissue Adhesive</title>
          <description>Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="110"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="110"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Bleeding requiring suture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="110"/>
              </event>
              <event>
                <sub_title>Infection requiring antibiotics</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="110"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Peter S. Millard, MD, PhD</name_or_title>
      <organization>University of New England</organization>
      <phone>2072992131</phone>
      <email>pmillard@mac.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
